Early treatments for COVID-19
The 5,680 treatments below have been reported as potentially beneficial for COVID-19. We currently review studies for:
acetaminophen adintrevimab alkalinization antiandrogens aspirin bamlanivimab/etesevimab bebtelovimab bromhexine budesonide cannabidiol casirivimab/imdevimab cetylpyridinium chloride chlorhexidine colchicine convalescent plasma curcumin diet ensitrelvir ensovibep exercise famotidine favipiravir fluvoxamine HCQ hydrogen peroxide ibuprofen indomethacin iota-carrageenan ivermectin lactoferrin melatonin metformin molnupiravir N-acetylcysteine nigella sativa nitazoxanide nitric oxide paxlovid peginterferon lambda phthalocyanine povidone-iodine probiotics proxalutamide quercetin remdesivir selenium sleep sotrovimab spironolactone sunlight tixagevimab/cilgavimab vitamin A vitamin B9 vitamin C vitamin D zinc
The following papers report potential benefits of 5,624 other treatments. We have not reviewed these studies.
clitoria ternatea, Asian pigeonwings, bluebellvine, blue pea, butterfly pea, cordofan pea, Darwin pea (1 study)
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note that studies are listed under the date they were first available, which may be the date of an earlier preprint.